CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

David Elkins

Executive VP & CFO, Bristol Myers Squibb

Search every verified David Elkins interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. David Elkins, executive vice president and CFO of Bristol Myers Squibb, participated in the company’s second quarter fiscal 2026 earnings call on July 30, 2026, where he discussed the company’s financial performance. He stated that the quarter’s results highlighted the strength of the growth portfolio, which includes products early in their life cycles, and cited disciplined investment in growth initiatives and the performance of Eloquis as contributing factors. He noted that, based on first-half momentum and confidence in the second-half outlook, the company was raising its full-year guidance for both revenue and adjusted diluted EPS. In a prior appearance on the fourth quarter 2024 earnings call in February 2025, Elkins addressed questions related to product performance and pipeline developments. He indicated that the company expected a PDUFA date in April for CAMZYOS and discussed efforts to ease the burden of echocardiogram requirements for patients and physicians, which he said would open additional capacity at centers of excellence. He also described the company’s priorities as delivering commercial execution, advancing pipeline catalysts, enhancing value creation through business development, and maintaining financial flexibility.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →